Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2009
11/11/2009CN101574372A Chinese medicament for external application for reducing temperature
11/11/2009CN101574364A Preparation capable of improving intelligence, height, athletic ability and immunity and preparation method
11/11/2009CN101574355A Compound antibacterial injection for livestock and preparation method thereof
11/11/2009CN101574351A Cefmetazole preparation used for injection and preparation method thereof
11/11/2009CN101574344A Niacin and statin medicinal composition and preparation method thereof
11/11/2009CN101574331A Lappaconitine transdermal patch and preparation method thereof
11/11/2009CN101574330A Rizatriptan benzoate film agent
11/11/2009CN101574329A Zolpidem tartrate film agent
11/11/2009CN101574328A Timing pulsed release micro-pill of zolpidem salt
11/11/2009CN101574327A Encapsulated agglomeration of microcapsules and method for the preparation thereof
11/11/2009CN101574326A Capsule preparation containing tegafur, Jimeisita and Potassium Oxonate and preparation method thereof
11/11/2009CN101574325A Sodium dichlorophenolate sustained-release tablet and method for controlling sustained-release of sodium dichlorophenolate sustained-release tablet
11/11/2009CN101574324A Felodipine sustained-release tablet and method for controlling sustained-release of Felodipine sustained-release tablet
11/11/2009CN101574323A Migltol microcapsule tablet and preparation method thereof
11/11/2009CN101574322A Bevantolol hydrochloride orally disintegrating tablet
11/11/2009CN101574318A Preparation method of taxol injection
11/11/2009CN100558903C Photochemical internalization for delivery of molecules into the cytosol
11/11/2009CN100558411C Tenascin-C nucleic acid ligands
11/11/2009CN100558409C Thiotungstate analogues and uses thereof
11/11/2009CN100558408C Calcium alginate gel bead with shell of porous calcium carbonate microsphere and its preparing method
11/11/2009CN100558407C Preparation of aqueous clear solution dosage forms with bile acids
11/11/2009CN100558406C Temperature sensing medicine carrying micelle with magnetothermal effect, preparation method and method of use thereof
11/11/2009CN100558405C Pharmaceutical compositions comprising cyclosporin
11/11/2009CN100558404C Water-solubility carrier
11/11/2009CN100558403C Double-shell medicine sustained and controlled releasing carrier material and preparation method and application thereof
11/11/2009CN100558398C Modified naturetic compounds, conjugates, and uses thereof
11/11/2009CN100558395C Hybrid peptide modulate immune response
11/11/2009CN100558365C Conjugated anti-psychotic drugs and uses thereof
11/11/2009CN100558364C Combination of brimonidine and timolol for topical ophthalmic use
11/11/2009CN100558350C Improved transdermal delivery system
11/11/2009CN100558345C Method for preparing vitamin A and vitamin E nano-sphere/microsphere double-embedding system
11/10/2009US7615593 Bifunctional-modified hydrogels
11/10/2009US7615547 Granulates containing liposoluble substances and a process for the preparation thereof
11/10/2009US7615540 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening
11/10/2009US7615539 Nucleic acid-lipophilic conjugates
11/10/2009US7615237 Percutaneously absorbable preparations
11/10/2009US7615236 Medical dressing for application and maintenance of medication on body tissue
11/10/2009US7615235 Film-shaped or wafer-shaped pharmaceutical preparation with masked taste
11/10/2009US7615233 Particulate construct comprising polyhydroxyalkanoate and method for producing it
11/10/2009US7615225 Methods for treating a subject having cancer by the administration of a conjugate between a variant staphylococcal entertoxin E superantigen and an antibody that binds to the 5T4 antigen
11/10/2009CA2459930C Method of treating middle ear infections
11/10/2009CA2444145C Preparation of formulations of angiotensin ii at1 receptors antagonists for the treatment of arterial hypertension, other cardiovascular illness and its complications
11/10/2009CA2397614C Honey based wound dressing
11/10/2009CA2353642C Biocompatible crosslinked polymers
11/10/2009CA2179382C Intrabuccally dissolving compressed moldings and production process thereof
11/05/2009WO2009135067A1 Pharmaceutical polish formulations
11/05/2009WO2009134958A2 Dog pheromone formulation and delivery system
11/05/2009WO2009134952A2 Potent conjugates and hydrophilic linkers
11/05/2009WO2009134947A1 Nicotine lozenge compositions
11/05/2009WO2009134042A2 Arborescent oligopeptide-containing cyclotriphosphazene, preparation method thereof and drug delivery system containing the same
11/05/2009WO2009133867A1 Liposome containing metal colloid
11/05/2009WO2009133863A1 Immunopotentiating agent comprising ep1 agonist
11/05/2009WO2009133774A1 Spherical granules and method of producing the same
11/05/2009WO2009133616A1 Versatile disinfectant
11/05/2009WO2009133545A2 Vascular delivery systems
11/05/2009WO2009133413A1 Formulation based on micronized clinoptilolite as a therapeutic agent for removal of toxins, bacteria and viruses from organism
11/05/2009WO2009133325A2 Polymerized micelles
11/05/2009WO2009133229A1 Metallo-organic system for the encapsulation and release of compounds of interest, method for obtaining same and uses thereof
11/05/2009WO2009133209A1 Inhibitors of bacterial tyrosine kinase and uses thereof
11/05/2009WO2009133137A2 Pegylated recombinant human growth hormone compounds
11/05/2009WO2009106991A3 Pyridazine derivatives and their use as therapeutic agents in the treatment of skin disorders
11/05/2009WO2009105192A3 Use of saccharides cross-reactive with bacillus anthracis spore glycoprotein as a vaccine against anthrax
11/05/2009WO2009104932A3 Composite preparation
11/05/2009WO2009098520A3 Composition and method for assisting swallowing
11/05/2009WO2009077153A8 Method for producing a hydroxyalkyl starch derivative with two linkers
11/05/2009WO2009061473A3 Photonic shell-core cross linked and functionalized nanostructures for biological applications
11/05/2009WO2009031026A3 Lamivudine-cyclodextrin complex
11/05/2009WO2008152508A3 Cytokine conjugate
11/05/2009WO2008148080A3 Pharmaceutical compositions of [5(s)-(2'-hydroxyethoxy)-20(s)-camptothecin]
11/05/2009WO2007117215A8 Binder for c-reactive protein
11/05/2009US20090275672 Sustained-Release Tablet Production Process
11/05/2009US20090275671 Two component bone cement composition for vertebroplasty
11/05/2009US20090275670 Dog pheromone formulation and delivery system
11/05/2009US20090275668 Sprayable Gel-Type Skin/Mucosa-Adhesive Preparation and Administration System Using the Preparation
11/05/2009US20090275664 Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
11/05/2009US20090275545 Medicinal targeted local lipolysis
11/05/2009US20090275540 Pre-Compacted Calcium-Containing Compositions
11/05/2009US20090275539 Nuclear Transcription Factors Regulators
11/05/2009US20090275526 Mucoadhesive nanoparticles for cancer treatment
11/05/2009US20090275513 Composition and method for preparing plasminogen
11/05/2009US20090275499 Nonstructural protein ns1 as a novel therapeutic target against flaviviruses
11/05/2009US20090274762 Rehydratable pharmaceutical product
11/05/2009US20090274760 Use of An Alkyl Glycoside Or Of A Mixture Of Alkyl Glycosides Having Anti-Ageing And/Or Calming Properties As Active Agents In Cosmetic Compositions, And Methods Of Cosmetic Care Using Said Compositions
11/05/2009US20090274748 Nonaqueous pressure-sensitive adhesive for medicinal tape preparation for percutaneous absorption, medicinal tape preparation for percutaneous absorption, and process for producing the same
11/05/2009US20090274733 Pharmaceutical preparation containing copolyvidone
11/05/2009US20090274708 Recombinant Toxin Fragments
11/05/2009US20090274658 Tight Junction Modulating Peptides for Enhanced Mucosal Delivery of Therapeutic Compounds
11/05/2009US20090274649 Bispecific Antibody Point Mutations for Enhancing Rate of Clearance
11/05/2009US20090274620 Hybridoma Cell Line G250 and its use for Producing Monoclonal Antibodies
11/05/2009CA2771879A1 Sulfoalkyl ether cyclodextrin compositions
11/05/2009CA2725601A1 Supercharged proteins for cell penetration
11/05/2009CA2723315A1 Vascular delivery systems
11/05/2009CA2723117A1 Versatile disinfectant
11/05/2009CA2723011A1 Nicotine lozenge compositions
11/05/2009CA2722050A1 Polymerized micelles
11/05/2009CA2721947A1 Pegylated recombinant human growth hormone compounds
11/05/2009CA2720516A1 Indoline anti-cancer agents
11/04/2009EP2113517A1 Complexes comprising angiostatin and its fragments, preparation preparing methods and uses thereof
11/04/2009EP2113256A1 PEGylated rhGH compounds
11/04/2009EP2113252A1 A forsythoside injection and preparation thereof
1 ... 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 ... 1712